Acute Tumor Lysis Syndrome during Oral Fludarabine Treatment for Chronic Lymphocytic Leukemia. Role of Treatment with Rasburicase

Publisher： Karger

E-ISSN： 2296-5262|31|4|197-199

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.4, 2008-03, pp. : 197-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Tumor Lysis Syndrome during Oral Fludarabine Treatment for CLL – a Rare Event that Might Be Observed More Frequently in the Future

By  

Oncology Research and Treatment, Vol. 31, Iss. 4, 2008-03 ,pp. : 157-158

Karger

Access to resources Recommend Favorite

Recombinant Urate Oxidase (Rasburicase) for the Prevention and Treatment of Tumor Lysis Syndrome in Patients with Hematologic Malignancies

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

New oral small molecules in the treatment of chronic lymphocytic leukemia

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1917-1926

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ofatumumab for the treatment of chronic lymphocytic leukemia

By Robak Tadeusz  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 577-587

Future Medicine

Access to resources Recommend Favorite

Acute Tumor Lysis Syndrome – a Rare Complication in the Treatment of Solid Tumors

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 498-499

Karger

Access to resources Recommend Favorite